Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Intraductal Papillary Mucinous Neoplasms × Secretin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 6 Peutz-Jeghers Syndrome 2 Exocrine Pancreatic Insufficiency 2 Intraductal Papillary Mucinous Neoplasms 1 Hereditary pancreatitis 1 Hereditary Sensory and Autonomic Neuropathies 1 Dysplastic Nevus Syndrome 1 Diabetes Mellitus 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Breast Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00621556 2009-01-29

Secretin Enhanced MRCP for Evaluation of the Known or Suspected Intraductal Papillary Mucinous Neoplasms of the Pancreas

Massachusetts General Hospital

Phase 1 Terminated

Intraductal Papillary Mucinous Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡